Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
Finding Wegovy can become a part-time job for patients, said Dr. Diana Thiara, medical director of the weight management clinic at the University of California, San Francisco.
One of Fitch’s patients, Mike Bouboulis, has taken Saxenda, Mounjaro or Ozempic, a Novo diabetes drug with the same active ingredient as Wegovy, since around 2019. It became much harder for him to find the drugs in the past year, after their popularity exploded.“They all know what you’re calling for, and they all have the same answer: ‘I don’t know. We’ll see tomorrow,’” said the 35-year-old small business owner who lives outside Boston.
Doctors and patients say many insurers have stopped covering Ozempic and Mounjaro outside their approved use for diabetes. Some insurers and employers don’t pay for Wegovy.Bouboulis, the Boston-area resident, said his insurer stopped covering Mounjaro earlier this year. He then tried switching back to Ozempic but found that also was no longer covered.
Davisson directs a weight-loss program in West Virginia, a state that consistently ranks as having one of the highest obesity rates in the country. The state’s Medicaid program doesn’t cover Wegovy, but neighboring Pennsylvania’s does.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
China conjures a glut of coal as record imports swell supplyThis time last year, Chinese coal prices were soaring as power plants scrambled for supplies after an historic drought caused hydropower output to collapse. The market for China’s mainstay fuel today is far more sedate. Although prices have crept higher in recent weeks, record imports and the impact of a fragile economy on consumption are likely to cap costs heading into the next period of peak demand over the winter. But that’s not to say pressure points on supply won’t emerge.
Weiterlesen »
Crude oil hits highest level this year; supply set to remain tight By Investing.comCrude oil hits highest level this year; supply set to remain tight
Weiterlesen »
Oil prices extend rally on China stimulus cheer, tight supply outlook By Investing.comOil prices extend rally on China stimulus cheer, tight supply outlook
Weiterlesen »
WTI surges to the fresh YTD high above the $90.10 mark amid tighter supply expectationsWestern Texas Intermediate (WTI), the US crude oil benchmark, is trading around $90.10 so far on Friday. WTI prices climb to the Year-To-Date (YTD) hi
Weiterlesen »
A Year After Ethereum Merge, Net Supply Down Nearly 300K EtherThe Merge marked the completion of Ethereum's transition to the proof-of-stake consensus mechanism.
Weiterlesen »